A multinational observational cohort study in acutely ill medical patients of practices in prevention of venous thromboembolism: Findings of the international medical prevention registry on venous thromboembolism (IMPROVE).

被引:0
|
作者
Tapson, VF
Decousus, H
Piovella, F
Zotz, RB
Allegrone, J
Anderson, FA
机构
[1] Duke Univ, Med Ctr, Durham, NC USA
[2] Ctr Hosp Univ Bellevue, St Etienne, France
[3] Policlin San Matteo, IRCCS, Serv Malattie Tromboemliche, I-27100 Pavia, Italy
[4] Univ Klinikum Dusseldorf, Dusseldorf, Germany
[5] Univ Massachusetts, Sch Med, Ctr Outcomes Res, Worcester, MA 01605 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1154
引用
收藏
页码:321A / 321A
页数:1
相关论文
共 50 条
  • [31] Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients
    Leizorovicz, A
    Cohen, AT
    Turpie, AGG
    Olsson, CG
    Vaitkus, PT
    Goldhaber, SZ
    CIRCULATION, 2004, 110 (07) : 874 - 879
  • [32] Influence of perceived risk factors for bleeding on venous thromboembolism prophylaxis practices in acutely Ill medical patients: Findings from IMPROVE
    Monreal, M
    Zotz, RB
    Decousus, H
    Chong, BH
    Merli, G
    Pavanello, R
    Pini, M
    Turpie, AG
    Huang, W
    Anderson, FA
    BLOOD, 2005, 106 (11) : 269A - 269A
  • [33] Prevention of venous thromboembolism among hospitalized medical patients
    Goldhaber, SZ
    Turpie, AGG
    CIRCULATION, 2005, 111 (01) : E1 - E3
  • [34] Primary prevention of venous thromboembolism in elderly medical patients
    Lacut, Karine
    Le Gal, Gregoire
    Mottier, Dominique
    CLINICAL INTERVENTIONS IN AGING, 2008, 3 (03) : 399 - 411
  • [35] Pharmacological prevention of venous thromboembolism in medical patients at risk
    Wolozinsky M.
    Yavin Y.Y.
    Cohen A.T.
    American Journal of Cardiovascular Drugs, 2005, 5 (6) : 409 - 415
  • [36] THE INFLUENCE OF AMBULATION ON THE RISK OF VENOUS THROMBOEMBOLISM IN ACUTELY ILL MEDICAL PATIENTS
    Amin, Alpesh
    Samama, Meyer
    Girard, Frederick
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2010, 25 : 409 - 409
  • [37] Risk assessment models for venous thromboembolism in acutely ill medical patients
    Stuck, Anna K.
    Spirk, David
    Schaudt, Jil
    Kucher, Nils
    THROMBOSIS AND HAEMOSTASIS, 2017, 117 (04) : 801 - 808
  • [38] Survey of prophylaxis against venous thromboembolism in acutely ill medical patients
    Peterman, CM
    Kolansky, D
    Spinler, S
    PHARMACOTHERAPY, 2004, 24 (10): : 1424 - 1425
  • [39] External Validation of the Risk Assessment Model of the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) for Medical Patients in a Tertiary Health System
    Rosenberg, David
    Eichorn, Ann
    Alarcon, Mauricio
    McCullagh, Lauren
    McGinn, Thomas
    Spyropoulos, Alex C.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2014, 3 (06):
  • [40] Rivaroxaban vs. enoxaparin for the prevention of venous thromboembolism in acutely ill medical patients: Magellan subgroup analyses
    Cohen, A. T.
    Spiro, T. E.
    Buller, H. R.
    Haskell, L.
    Hu, D.
    Hull, R.
    Mebazaa, A.
    Merli, G.
    Schellong, S.
    Spyropoulos, A.
    Tapson, V.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 21 - 21